Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

XVIVO Perfusion AB Receives Marketing Approval for Steen Solution in Canada


Thursday, 8 Nov 2012 07:30am EST 

XVIVO Perfusion AB announced that it has gained marketing clearance from the Canadian regulatory authorities (Health Canada) for Steen Solution. The Company has an ongoing multicenter trial in the United States for STEEN Solution and has submitted an application to the FDA to market it there. XVIVO Perfusion has previously obtained marketing approval for STEEN Solution in the markets outside North America.